At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
8-iso Prostaglandin F2α and Adenosine Deaminaseother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Exploring 8-iso Prostaglandin F2α and Adenosine Deaminase Levels in Periodontal Health and Disease
In Brief
A clinical study evaluating 8-iso Prostaglandin F2α and Adenosine Deaminase for Periodontal Diseases. Completed, enrolled 80 participants across 1 site.
Detailed Summary
This study aims to assess the diagnostic potential of gingival crevicular fluid (GCF) biomarkers, specifically 8-iso Prostaglandin F2α (8-iso-PGF2α) and adenosine deaminase (ADA), in evaluating periodontal health and disease conditions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeriodontal Diseases
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartOct 2023
Primary CompletionDec 2023
Study CompletionJan 2024
First PostedFeb 2024
TodayJul 2026
First PostedFeb 1, 2024
Enrollment StartOct 1, 2023
Primary CompletionDec 31, 2023
Study CompletionJan 15, 2024
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 2.4 years ago
Interventions
8-iso Prostaglandin F2α and Adenosine Deaminaseother
We took gingival crevicular fluid samples from patients who applied to our clinic and evaluated the -iso Prostaglandin F2α and Adenosine Deaminase levels in the samples.